Renal primitive neuroectodermal tumor. The first case series from Syria.

Case series Immunohistochemical Neuroectodermal PNET Renal Renal neoplasms

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 22 07 2022
revised: 12 09 2022
accepted: 18 09 2022
entrez: 21 10 2022
pubmed: 22 10 2022
medline: 22 10 2022
Statut: epublish

Résumé

Primitive neuroectodermal tumor (PNET) mainly arises from soft tissues of the extremities such as humerus, femur, C tibia. It rarely arises from kidney; less than 200 cases have been reported in the literature. The clinical presentation and radiography findings are not specific. Here we first report two cases of renal primitive neuroectodermal tumor in Syria. the first patient was 26-year-old- female that presented to urology clinic complaining of right flank pain. Ultrasonography of the abdomen showed a large mixed heterogeneous mass in the right kidney with no hemorrhage or calcification and MSCT of abdomen and pelvis demonstrate a mixed well-demarcated heterogeneous mass measuring (74*117) mm in the right kidney right radical nephrectomy was performed. The second patient 19-year-old-male presented with left flank pain. Ultrasonography of the abdomen showed mixed large mass involving the left kidney, with unmarked border. The CT of the abdomen and pelvis demonstrating a (30*110*90) mm left renal mass and periaortic lymphadenopathy measuring (45*28) mm. The patient underwent Left radical nephrectomy with periaortic lymphadenectomy dissection. The final diagnosis for both cases was Renal PNET based on microscopic and immunohistochemistry examination. In patient with suspected renal mass in the radiographic images, the diagnosis of renal primitive neuroectodermal tumor should be kept in the mind despite its rarity. The final diagnosis is done by histopathological study in association with immunohistochemical examination.

Identifiants

pubmed: 36268368
doi: 10.1016/j.amsu.2022.104740
pii: S2049-0801(22)01500-X
pmc: PMC9577866
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104740

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Australas Radiol. 2004 Jun;48(2):211-3
pubmed: 15230757
Am J Surg Pathol. 2002 Mar;26(3):320-7
pubmed: 11859203
Urology. 2013 Feb;81(2):347-53
pubmed: 23374800
Perspect Pediatr Pathol. 1975;2:151-72
pubmed: 1129029
Urol Ann. 2019 Jan-Mar;11(1):105-108
pubmed: 30787583
Lancet Oncol. 2010 Feb;11(2):184-92
pubmed: 20152770
Am J Surg Pathol. 2001 Feb;25(2):133-46
pubmed: 11176062
Ther Adv Urol. 2013 Jun;5(3):153-9
pubmed: 23730330
Urology. 2006 Aug;68(2):257-62
pubmed: 16904430
BMC Cancer. 2004 Jan 26;4:3
pubmed: 14969593
Am J Surg Pathol. 1997 Mar;21(3):354-9
pubmed: 9060607
Int J Surg. 2020 Dec;84:231-235
pubmed: 33189880

Auteurs

Ahmad Al Mousa (A)

Department of Urology, Aleppo University Hospital, Aleppo, Syria.

Mohammad Nour Kitaz (MN)

Neurosurgery Department, Aleppo University Hospital, Aleppo, Syria.

Muhamad Zakaria Brimo Alsaman (MZ)

Faculty of Medicine, University of Aleppo, Aleppo, Syria.

Vairy Rezkallah (V)

Department of Pathology, Aleppo University Hospital, Aleppo, Syria.

Lina Ghabreau (L)

Department of Pathology, Aleppo University Hospital, Aleppo, Syria.

Ibrahim Al-Hadid (I)

Department of Urology, Aleppo University Hospital, Aleppo, Syria.

Classifications MeSH